Join

Compare · BYAH vs HLN

BYAH vs HLN

Side-by-side comparison of Park Ha Biological Technology Co. Ltd. (BYAH) and Haleon plc (HLN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BYAH and HLN operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
  • HLN is the larger of the two at $38.83B, about 6458.5x BYAH ($6.0M).
  • Over the past year, BYAH is down 99.8% and HLN is down 20.3% - HLN leads by 79.5 points.
  • HLN has been more active in the news (9 items in the past 4 weeks vs 2 for BYAH).
  • HLN has more recent analyst coverage (19 ratings vs 0 for BYAH).
PerformanceBYAH-99.83%HLN-21.48%
2025-06-04+0.00%2026-06-02
MetricBYAHHLN
Company
Park Ha Biological Technology Co. Ltd.
Haleon plc
Price
$1.20-0.83%
$8.72+0.11%
Market cap
$6.0M
$38.83B
1M return
+10.09%
-5.73%
1Y return
-99.83%
-20.29%
Sector
Consumer Discretionary
Consumer Discretionary
Industry
Package Goods/Cosmetics
Package Goods/Cosmetics
Exchange
NASDAQ
NYSE
IPO
2024
2022
News (4w)
2
9
Recent ratings
0
19
HLN

Haleon plc

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.

Latest BYAH

Latest HLN